Cargando…
Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL
Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651953/ https://www.ncbi.nlm.nih.gov/pubmed/36222652 http://dx.doi.org/10.7554/eLife.81606 |
_version_ | 1784828360952643584 |
---|---|
author | Stevens, Donté Alexander Beierschmitt, Christopher Mahesula, Swetha Corley, Miles R Salogiannis, John Tsu, Brian V Cao, Bryant Ryan, Andrew P Hakozawki, Hiroyuki Reck-Peterson, Samara L Daugherty, Matthew D |
author_facet | Stevens, Donté Alexander Beierschmitt, Christopher Mahesula, Swetha Corley, Miles R Salogiannis, John Tsu, Brian V Cao, Bryant Ryan, Andrew P Hakozawki, Hiroyuki Reck-Peterson, Samara L Daugherty, Matthew D |
author_sort | Stevens, Donté Alexander |
collection | PubMed |
description | Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor, ninein-like (NINL), as a critical component in the antiviral innate immune response and as a target of viral antagonism. Unique among genes encoding components of active dynein complexes, NINL has evolved under recurrent positive (diversifying) selection, particularly in its carboxy-terminal cargo-binding region. Consistent with a role for NINL in host immunity, we demonstrate that NINL knockout cells exhibit an impaired response to interferon, resulting in increased permissiveness to viral replication. Moreover, we show that proteases encoded by diverse picornaviruses and coronaviruses cleave and disrupt NINL function in a host- and virus-specific manner. Our work reveals the importance of NINL in the antiviral response and the utility of using signatures of host–virus genetic conflicts to uncover new components of antiviral immunity and targets of viral antagonism. |
format | Online Article Text |
id | pubmed-9651953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-96519532022-11-15 Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL Stevens, Donté Alexander Beierschmitt, Christopher Mahesula, Swetha Corley, Miles R Salogiannis, John Tsu, Brian V Cao, Bryant Ryan, Andrew P Hakozawki, Hiroyuki Reck-Peterson, Samara L Daugherty, Matthew D eLife Immunology and Inflammation Viruses interact with the intracellular transport machinery to promote viral replication. Such host–virus interactions can drive host gene adaptation, leaving signatures of pathogen-driven evolution in host genomes. Here, we leverage these genetic signatures to identify the dynein activating adaptor, ninein-like (NINL), as a critical component in the antiviral innate immune response and as a target of viral antagonism. Unique among genes encoding components of active dynein complexes, NINL has evolved under recurrent positive (diversifying) selection, particularly in its carboxy-terminal cargo-binding region. Consistent with a role for NINL in host immunity, we demonstrate that NINL knockout cells exhibit an impaired response to interferon, resulting in increased permissiveness to viral replication. Moreover, we show that proteases encoded by diverse picornaviruses and coronaviruses cleave and disrupt NINL function in a host- and virus-specific manner. Our work reveals the importance of NINL in the antiviral response and the utility of using signatures of host–virus genetic conflicts to uncover new components of antiviral immunity and targets of viral antagonism. eLife Sciences Publications, Ltd 2022-10-12 /pmc/articles/PMC9651953/ /pubmed/36222652 http://dx.doi.org/10.7554/eLife.81606 Text en © 2022, Stevens, Beierschmitt et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Immunology and Inflammation Stevens, Donté Alexander Beierschmitt, Christopher Mahesula, Swetha Corley, Miles R Salogiannis, John Tsu, Brian V Cao, Bryant Ryan, Andrew P Hakozawki, Hiroyuki Reck-Peterson, Samara L Daugherty, Matthew D Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title | Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title_full | Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title_fullStr | Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title_full_unstemmed | Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title_short | Antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor NINL |
title_sort | antiviral function and viral antagonism of the rapidly evolving dynein activating adaptor ninl |
topic | Immunology and Inflammation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651953/ https://www.ncbi.nlm.nih.gov/pubmed/36222652 http://dx.doi.org/10.7554/eLife.81606 |
work_keys_str_mv | AT stevensdontealexander antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT beierschmittchristopher antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT mahesulaswetha antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT corleymilesr antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT salogiannisjohn antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT tsubrianv antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT caobryant antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT ryanandrewp antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT hakozawkihiroyuki antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT reckpetersonsamaral antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl AT daughertymatthewd antiviralfunctionandviralantagonismoftherapidlyevolvingdyneinactivatingadaptorninl |